Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.

Corradini S, Pazos M, Schönecker S, Reitz D, Niyazi M, Ganswindt U, Schrodi S, Braun M, Pölcher M, Mahner S, Harbeck N, Engel J, Belka C.

Radiat Oncol. 2018 Feb 9;13(1):25. doi: 10.1186/s13014-018-0964-7.

2.

[Changes to cervical cancer screening in Germany].

Starrach T, Gallwas J, Blankenstein T, Mahner S, Dannecker C.

MMW Fortschr Med. 2018 Feb;160(2):46-51. doi: 10.1007/s15006-018-0152-6. Review. German. No abstract available.

PMID:
29417509
3.

Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.

Zhu J, Trillsch F, Mayr D, Kuhn C, Rahmeh M, Hofmann S, Vogel M, Mahner S, Jeschke U, von Schönfeldt V.

Oncotarget. 2017 Dec 9;9(1):982-994. doi: 10.18632/oncotarget.23140. eCollection 2018 Jan 2.

4.

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.

Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B; SUCCESS Study Group.

BMC Cancer. 2018 Feb 6;18(1):141. doi: 10.1186/s12885-018-4020-7.

5.

Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology.

Kolben T, Haberland B, Degenhardt T, Burgmann M, Koenig A, Kolben TM, Ulbach K, Mahner S, Bausewein C, Harbeck N, Wuerstlein R.

Arch Gynecol Obstet. 2018 Mar;297(3):767-773. doi: 10.1007/s00404-018-4681-0. Epub 2018 Jan 23.

PMID:
29362923
6.

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.

Schulz H, Kuhn C, Hofmann S, Mayr D, Mahner S, Jeschke U, Schmoeckel E.

Int J Mol Sci. 2018 Jan 22;19(1). pii: E323. doi: 10.3390/ijms19010323.

7.

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium.

Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B.

Oncotarget. 2017 Nov 16;8(63):106415-106428. doi: 10.18632/oncotarget.22468. eCollection 2017 Dec 5.

8.

Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer.

Vattai A, Cavailles V, Sixou S, Beyer S, Kuhn C, Peryanova M, Heidegger H, Hermelink K, Mayr D, Mahner S, Dannecker C, Jeschke U, Kost B.

Oncotarget. 2017 Oct 31;8(62):105356-105371. doi: 10.18632/oncotarget.22187. eCollection 2017 Dec 1.

9.

No need for NMDA receptor antibody screening in neurologically asymptomatic patients with ovarian teratomas.

Trillsch F, Eichhorn P, Oliveira-Ferrer L, Kuempfel T, Burges A, Mahner S, Havla J.

J Neurol. 2018 Feb;265(2):431-432. doi: 10.1007/s00415-017-8717-3. Epub 2017 Dec 22. No abstract available.

PMID:
29273845
10.

[Breast cancer in male].

Würstlein R, Hesse A, König A, Schulte-Vorwick F, Schrodi S, Ditsch N, Mahner S, Harbeck N.

MMW Fortschr Med. 2017 Dec;159(21-22):67-72. doi: 10.1007/s15006-017-0395-7. Review. German. No abstract available.

PMID:
29230744
11.

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.

Kolben T, Jeschke U, Reimer T, Karsten N, Schmoeckel E, Semmlinger A, Mahner S, Harbeck N, Kolben TM.

J Cancer Res Clin Oncol. 2018 Feb;144(2):249-256. doi: 10.1007/s00432-017-2551-y. Epub 2017 Nov 28.

PMID:
29185091
12.

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer.

Prieske K, Prieske S, Joosse SA, Trillsch F, Grimm D, Burandt E, Mahner S, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L, Woelber L.

Oncotarget. 2017 Sep 15;8(47):83063-83074. doi: 10.18632/oncotarget.20945. eCollection 2017 Oct 10.

13.

Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium.

Zhu J, Mayr D, Kuhn C, Mahner S, Jeschke U, von Schönfeldt V.

Histochem Cell Biol. 2018 Feb;149(2):153-160. doi: 10.1007/s00418-017-1616-y. Epub 2017 Nov 13.

PMID:
29134301
14.

Blasenschwäche: Was Sie als Hausarzt wissen sollten.

Stief C, Mahner S.

MMW Fortschr Med. 2017 Nov;159(19):48. doi: 10.1007/s15006-017-0276-0. Review. German. No abstract available.

PMID:
29124584
15.

[Urinary incontinence in women].

Burgmann M, Mahner S, Dannecker C.

MMW Fortschr Med. 2017 Nov;159(19):49-52. doi: 10.1007/s15006-017-0277-z. Review. German. No abstract available.

PMID:
29124583
16.

RE: Post-traumatic Stress as the Primary Cause for Cognitive Decline-Not the Whole Story, and Perhaps No Story at All.

Hermelink K, Bühner M, Münzel K, Mahner S, Harbeck N.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx147. No abstract available.

PMID:
29117358
17.

Role of Placental VDR Expression and Function in Common Late Pregnancy Disorders.

Knabl J, Vattai A, Ye Y, Jueckstock J, Hutter S, Kainer F, Mahner S, Jeschke U.

Int J Mol Sci. 2017 Nov 6;18(11). pii: E2340. doi: 10.3390/ijms18112340. Review.

18.

Vitamin D and VDR in Gynecological Cancers-A Systematic Review.

Deuster E, Jeschke U, Ye Y, Mahner S, Czogalla B.

Int J Mol Sci. 2017 Nov 4;18(11). pii: E2328. doi: 10.3390/ijms18112328. Review.

19.

Human placental growth hormone in ectopic pregnancy: Detection in maternal blood, immunohistochemistry and potential clinical implication.

Hübener C, Bidlingmaier M, Wu Z, Diebold J, Strasburger CJ, Mahner S, Hasbargen U, Delius M.

Growth Horm IGF Res. 2017 Dec;37:13-18. doi: 10.1016/j.ghir.2017.10.004. Epub 2017 Oct 14.

PMID:
29073481
20.

Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only.

Hertlein L, Rath J, Zeder-Göss C, Fürst S, Bayer D, Trillsch F, Mahner S, Burges A, Jeschke U.

Oncol Lett. 2017 Sep;14(3):3302-3308. doi: 10.3892/ol.2017.6592. Epub 2017 Jul 18.

Supplemental Content

Loading ...
Support Center